← All indications
Carcinoma, Ductal
Malignant neoplasms involving the ductal systems of any of a number of organs, such as the MAMMARY GLANDS, the PANCREAS, the PROSTATE, or the LACRIMAL GLAND.
Subtype terms (2)
More specific conditions that are subtypes of Carcinoma, Ductal in the MeSH hierarchy.
- Carcinoma, Ductal, Breast
13 drugs (8 approved, 5 experimental)
- Carcinoma, Pancreatic Ductal
50 drugs (32 approved, 18 experimental)
Drugs by status
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (14)
- Halozyme Therapeutics
- National Cancer Institute (NCI)
- Kaohsiung Medical University
- Kyoto University
- NRG Oncology
- North Central Cancer Treatment Group
- Southwest Oncology Group
- Jiao Tong University
- NSABP Foundation
- National Taiwan University
- Sun Yat-Sen University
- American College of Surgeons
- Government of Taiwan
- Mackay Medical College
Organization Involved with Phase 2 Indications (53)
- Incyte
- Celgene
- Shire
- Amgen
- AstraZeneca
- Eli Lilly
- Sanofi
- Sanofi-Aventis
- AIO-Studien-gGmbH
- Atossa Genetics, Inc.
- Baxalta
- Bayer
- G1 Therapeutics, Inc.
- GlaxoSmithKline
- Windy Hill Medical, Inc.
- West German Study Group
- United States Army
- Huazhong University of Science and Technology
- Academic and Community Cancer Research United
- University of Pittsburgh
- Baylor University
- University of London
- Harvard University
- Duke University
- Federation Francophone de Cancerologie Digestive
- George Mason University
- Jilin University
- Johns Hopkins University
- New York University
- Paracelsus Medical University
- +23 more
Organization Involved with Phase 1 Indications (13)
- Curegenix Inc.
- Montefiore Medical Center
- University of Pennsylvania
- Temple University
- University of Washington
- Utrecht University
- Columbia University
- University of California, Los Angeles
- University of California, San Diego
- Van Andel Research Institute
- Yeshiva University
- Chinese Academy of Medical Sciences
- Jacobio Pharmaceuticals Co., Ltd.
Organization Involved with Other Experimental Indications (5)